Tullis — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
CXL OPHTHALMICS, INC.Sep 2022SEC filingmedium confidence
BiotechSherborn, US
MARC ODRICH(Director)JONATHAN TALAMO(Director)EDWARD PARSONS(Executive Officer)SUSAN MACDONALD(Director)MICHAEL WEBB(Executive Officer, Director)
Board seatCurt Labelle· per SEC Form D · $50.3M raise · filed Oct 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.